Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 9:6:32804.
doi: 10.1038/srep32804.

CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis

Xiaoyan Xin  1 , Xianqin Zeng  2 , Huajian Gu  3 , Min Li  1   4 , Huaming Tan  5 , Zhishan Jin  1 , Teng Hua  1 , Rui Shi  1 , Hongbo Wang  1
Affiliations

CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis

Xiaoyan Xin et al. Sci Rep. .

Abstract

CD147/EMMPRIN (extracellular matrix metalloproteinase inducer) plays an important role in tumor progression and a number of studies have suggested that it is an indicator of tumor prognosis. This current meta-analysis systematically reevaluated the predictive potential of CD147/EMMPRIN in various cancers. We searched PubMed and Embase databases to screen the literature. Fixed-effect and random-effect meta-analytical techniques were used to correlate CD147 expression with outcome measures. A total of 53 studies that included 68 datasets were eligible for inclusion in the final analysis. We found a significant association between CD147/EMMPRIN overexpression and adverse tumor outcomes, such as overall survival, disease-specific survival, progression-free survival, metastasis-free survival or recurrence-free survival, irrespective of the model analysis. In addition, CD147/EMMPRIN overexpression predicted a high risk for chemotherapy drugs resistance. CD147/EMMPRIN is a central player in tumor progression and predicts a poor prognosis, including in patients who have received chemo-radiotherapy. Our results provide the evidence that CD147/EMMPRIN could be a potential therapeutic target for cancers.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3. Qualitative meta-analysis of the association between CD147/EMMPRIN over-expression and overall survival (OS) in cancer patients.
Panel A, represents the association of CD147/EMMPRIN positive expression with worse OS in multivariate model, while panel B, represents similar association by univariate model.
Figure 4
Figure 4. Qualitative meta-analysis of the association between CD147/EMMPRIN over-expression and PFS/MFS/RFS in cancer patients.
Panel (A) represents the overall association of CD147/EMMPRIN positive expression with worse PFS/MFS/RFS in multivariate model; panel (B) depicts similar association in univariate model.
Figure 5
Figure 5. Qualitative meta-analysis of the association between CD147/EMMPRIN over-expression and disease free survival (DSS) in cancer patients, and to predict easier recurrence of drug resistance.
Panel A, represents the association of CD147/EMMPRIN positive expression with worse DSS in multivariate model. Panels B, represents the potential of CD147/EMMPRIN positive expression to predict easier recurrence of drug resistance.
Figure 6
Figure 6. Assessment of publication bias for OS, DSS, and PFS/MFS/RFS studies.
Panel (A) depicts the assessment of publication bias for multivariate model studies, by funnel plot analysis, whereas panel (B) shows funnel plot analysis using nonparametric Trim and Fill method. Panel (C) represents the publication bias in univariate model studies. Panel (D) represents the assessment of publication bias for multivariate model. Panels (E,F) represents assessment of publication bias for multivariate and univariate model studies, respectively.
See this image and copyright information in PMC

References

    1. Huang P. et al. RNA interference targeting CD147 inhibits the proliferation, invasiveness, and metastatic activity of thyroid carcinoma cells by down-regulating glycolysis. Int J Clin Exp Pathol. 8, 309–318 (2015). - PMC - PubMed
    1. Grass G. D. & Toole B. P. How, with whom and when: an overview of CD147 mediated regulatory networks influencing matrix metalloproteinase activity. Biosci Rep. 24, 36(1) (2015). - PMC - PubMed
    1. Pinheiro C. et al. Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas. BMC Cancer. 15, 835 (2015). - PMC - PubMed
    1. Li S., Nguyen T. T. & Bonanno J. A. CD147 required for corneal endothelial lactate transport. Invest Ophthalmol Vis Sci. 55, 4673–81 (2014) - PMC - PubMed
    1. Als A. B. et al. Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer. Clin Cancer Res. 13, 4407–4414 (2007). - PubMed

Publication types